Role of mutated genes in development of schizophrenia
24 January 2013
Johns Hopkins researchers have identified a rare gene mutation in a single family with a high rate of schizophrenia, adding to evidence that abnormal genes play a role in the development of the disease.
The researchers, in a report published in the journal Molecular Psychiatry, say that family members with the mutation in the gene Neuronal PAS domain protein 3 (NPAS3) appear at high risk of developing schizophrenia or another debilitating mental illnesses.
Normally functioning NPAS3 regulates the development of healthy neurons, especially in a region of the brain known as the hippocampus, which appears to be affected in schizophrenia.
The Johns Hopkins researchers say they have evidence that the mutation found in the family may lead to abnormal activity of NPAS3, which has implications for brain development and function.
"Understanding the molecular and biological pathways of schizophrenia is a powerful way to advance the development of treatments that have fewer side effects and work better than the treatments now available," says study leader Frederick C Nucifora Jr, PhD, DO, MHS, an assistant professor of psychiatry and behavioural sciences at the Johns Hopkins University School of Medicine. "We could definitely use better medicines."
Along with environmental factors, it is widely believed that many genes play some role in causing schizophrenia, a disease characterised by a variable combination of hallucinations, delusions, impaired cognition and a loss of drive and initiative.